Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × Dasatinib × Clear all

NCT00470054 2015-05-05

Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer

Phase 2 Completed

44 enrolled 10 charts

Small Cell Lung Carcinoma